4
Changes in Ownership
Rapport Therapeutics, Inc. Filed Acc 0001193125-26-323637
Chief Executive Officer sold 2,210 shares at an average $42.11 ($93,061)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ceesay Abraham Chief Executive Officer | 2026-07-27 | Sale 10b5-1 | −2,203 | $42.11 | $92,762 | 537,614 | D |
| Ceesay Abraham Chief Executive Officer | 2026-07-27 | Sale 10b5-1 | −7 | $42.74 | $299 | 537,607 | D |
| Open-market sales · 2,210 sh · avg $42.11 · $93,061 | |||||||
Loading xslF345X06/ownership.xml…